Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Effect of Ianalumab Plus Eltrombopag on Patient-Reported Outcomes in Primary Immune Thrombocytopenia: Results from the VAYHIT2 Phase 3 Trial

MDS - 435

Effect of Ianalumab Plus Eltrombopag on Patient-Reported Outcomes in Primary Immune Thrombocytopenia: Results from the VAYHIT2 Phase 3 Trial

Mary Lisha Paul

Poster Presenter: Mary Lisha Paul

Thumbnail for Improving Survival and Increasing Disease Burden in Chronic Myelomonocytic Leukemia: Population-Based Trends and Projections From SEER, 2000-2022

MDS - 456

Improving Survival and Increasing Disease Burden in Chronic Myelomonocytic Leukemia: Population-Based Trends and Projections From SEER, 2000-2022

Arjun Syal

Poster Presenter: Arjun Syal

Previous 1...95 96 97 98 99 100 101...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Clonal Hematopoiesis Associated With Chronic Biomass-Smoke Exposure in Indigenous Tribal Populations of Maharashtra, India: A Pilot Molecular Screening Study

MDS - 499

Clonal Hematopoiesis Associated With Chronic Biomass-Smoke Exposure in Indigenous Tribal Populations of Maharashtra, India: A Pilot Molecular Screening Study

Maitri Gada

Poster Presenter: Maitri Gada

Thumbnail for Durable Complete Remission Following HMA Therapy in Higher-Risk MDS Is Not Fully Determined by Baseline Disease Biology

MDS - 515

Durable Complete Remission Following HMA Therapy in Higher-Risk MDS Is Not Fully Determined by Baseline Disease Biology

Julie Braish

Poster Presenter: Julie Braish

Thumbnail for THE VEXUS- MDS INTERFACE: INTEGRATING MORPHOLOGICAL MARKERS AND CLONAL EVOLUTION TO PREDICT RESPONSE TO TARGETED MYELOID CELL THERAPIES

MDS - 540

THE VEXUS- MDS INTERFACE: INTEGRATING MORPHOLOGICAL MARKERS AND CLONAL EVOLUTION TO PREDICT RESPONSE TO TARGETED MYELOID CELL THERAPIES

Teshika Yalla

Poster Presenter: Teshika Yalla

Thumbnail for Hematologic Manifestations and Clonal Hematopoiesis in Telomere Biology Disorders: A Retrospective Single-Center Cohort Study

MDS - 565

Hematologic Manifestations and Clonal Hematopoiesis in Telomere Biology Disorders: A Retrospective Single-Center Cohort Study

Olisaemeka Ogbue

Poster Presenter: Olisaemeka Ogbue

Thumbnail for ATLAS: A Randomized, Double-Blind, Placebo-Controlled, Adaptive Seamless Phase 2/3 Study to Assess the Safety and Efficacy of Momelotinib in Patients With VEXAS Syndrome

MDS - 583

ATLAS: A Randomized, Double-Blind, Placebo-Controlled, Adaptive Seamless Phase 2/3 Study to Assess the Safety and Efficacy of Momelotinib in Patients With VEXAS Syndrome

Shuyan Huang

Poster Presenter: Shuyan Huang

Thumbnail for Effects of Ianalumab Treatment on B-Cell Activation, Maturation, and Maintenance of Vaccine Titers in Patients With Primary Immune Thrombocytopenia (ITP) in the Phase 2 VAYHIT3 Study

MDS - 600

Effects of Ianalumab Treatment on B-Cell Activation, Maturation, and Maintenance of Vaccine Titers in Patients With Primary Immune Thrombocytopenia (ITP) in the Phase 2 VAYHIT3 Study

Jenny Despotovic

Poster Presenter: Jenny Despotovic

Thumbnail for Treatment of higher risk Myelodysplastic Syndrome HR-MDS with high-dose chemotherapy followed by lenalidomide and azacitidine: a four-year survival update

MDS - 635

Treatment of higher risk Myelodysplastic Syndrome HR-MDS with high-dose chemotherapy followed by lenalidomide and azacitidine: a four-year survival update

Maher Salamoon

Poster Presenter: Maher Salamoon

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.